top of page
H2C Securities Inc. Welcomes New Managing Director Kaustubh Wahal for M&A

November 2021

Kaustubh Wahal Headshot

NEW YORK - H2C Securities Inc. (“H2C”), a healthcare-focused strategic advisory and investment banking firm, is pleased to announce the expansion of its mergers and acquisitions (“M&A”) team with the addition of Kaustubh Wahal as a Managing Director in H2C’s New York office.

Mr. Wahal brings nearly two decades of investment banking and strategic finance experience to H2C, advising publicly traded and private organizations on valuation, tactics and positioning, buy-side advisory, competitive sell-side processes, negotiated transactions, and more. His capital raising experience includes providing advice to both public and private organizations related to equity, equity-linked, and debt instruments (investment-grade and high-yield) for event-related transactions, and regular course financings.

Much of his investment banking career has been devoted to healthcare, with a strong focus on healthcare services, including managed care, health systems, distributors, healthcare IT, and other services providers.

Mr. Wahal has advised on transactions with total cumulative value in excess of $150 billion, including Aetna’s acquisition of Coventry Health, Anthem’s acquisition of Simply Healthcare, IBM’s acquisition of Truven, CVS’ acquisition of Aetna (acquisition financing), CD&R’s acquisition of Cardinal Health’s stake in naviHealth, the merger of Thermo Electron and Fisher Scientific, United Healthcare’s acquisition of Sierra Health, and Cardinal Health’s acquisition of Medtronic assets (acquisition financing), along with numerous other engagements of various sizes and structures.

Prior to joining H2C, Mr. Wahal led the healthcare business of Corporate Advisory Group at MUFG, engaging with clients to develop long-term relationships and provide acquisition financing in conjunction with strategic advice. He began his investment banking career in 2004 in New York at Citigroup and further developed his expertise and skills in client engagement at Lehman Brothers (acquired by BarCap), Lazard Freres, and UBS Investment Bank.

“We are very pleased to welcome Kaustubh Wahal as a senior leader for H2C’s M&A team,” says William B. Hanlon III, Managing Director, H2C. “Kaustubh is a strategist and an M&A advisor focused on growth and value creation. He has advised clients in all healthcare sectors on growth strategy, optimal capital allocation, and more, and he is an excellent addition to our team.”

“I look forward to working with H2C’s esteemed M&A team and in making a significant impact for organizations across healthcare sectors,” Mr. Wahal says. “This is an excellent opportunity to put my skills in investment banking and strategic finance to work in service of our clients.”


Mr. Wahal earned Bachelor of Science degrees in Finance and Economics with Honors from Barret Honors College and W. P. Carey School of Business at Arizona State University. He also holds a degree in Animal Biology (Zoology) with Honors from the University of Delhi, India. Mr. Wahal resides with his wife and son in New York. He may be reached at

About H2C Securities Inc. 

H2C is a strategic advisory and investment banking firm committed to providing superior advice to healthcare organizations and related companies throughout the United States. H2C’s professionals have a long track record of success in healthcare mergers and acquisitions, capital markets, real estate, and restructuring transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value.

Securities and services offered through H2C Securities Inc., member FINRA/SIPC, a registered broker-dealer and an indirect subsidiary of Fifth Third Bank, National Association. All rights reserved. Securities and services offered through H2C Securities Inc.: Are Not FDIC Insured; Offer No Bank Guarantee; May Lose Value; Are Not Insured by any Federal Government Agency; Are Not a Deposit. 

bottom of page